Cytokinetics Stock News

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affimed NV (NASDAQ: AFMD)...

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Akero Therapeutics Inc (...

Stocks Analysis by Harry Boxer covering: BioCryst Pharmaceuticals Inc, Cytokinetics Inc, Vaxart Inc, Novavax Inc. Read Harry Boxer's latest article on Investing.com

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ADMA Biologics

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 6) ACADIA Pharmaceuticals Inc...

SOUTH SAN FRANCISCO, Calif., July 01, 2020 -- Cytokinetics, Incorporated (Nasdaq: CYTK), today announced that it will host a Virtual Investor and Analyst Day on Wednesday, July.

Let's check the charts and indicators.

Arizona Metals Corp. (TSX.V:AMC) (the “Company” or “Arizona Metals”) is pleased to announce that drilling at the South Zone of its Kay Mine Project, l

SPRINGFIELD, Ill. (AP) - Every baby newly born in Illinois will be tested for Spinal Muscular Atrophy starting Monday, state health officials said. The Illinois Department of Public Health said Spin

SPRINGFIELD, Ill. (AP) — Every baby newly born in Illinois will be tested for Spinal Muscular Atrophy starting Monday, state health officials said. The Illinois Department of Public Health...

Foresite Capital Management IV LLC reduced its stake in shares of Cytokinetics, Inc. (NASDAQ:CYTK) by 9.2% in the first quarter, according to its most recent filing with the SEC. The institutional inv

Two Sigma Advisers LP boosted its holdings in shares of Cytokinetics, Inc. (NASDAQ:CYTK) by 29.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Comm

Federated Hermes Inc. lowered its stake in shares of Cytokinetics, Inc. (NASDAQ:CYTK) by 97.7% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 2,224 shares of t

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 22) ADC Therapeutics SA (...

Cytokinetics, Inc. (NASDAQ:CYTK) Director Sandford D. Smith sold 6,907 shares of the firm’s stock in a transaction on Wednesday, June 17th. The shares were sold at an average price of $23.00, for a